Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides

Circulation Research
P S SpectorMichael C Sanguinetti

Abstract

We recently reported that mutations in HERG, a potassium channel gene, cause long QT syndrome. Heterologous expression of HERG in Xenopus oocytes revealed that this channel had biophysical properties nearly identical to a cardiac delayed rectifier K+ current I(Kr), but had dissimilar pharmacological properties. Class III antiarrhythmic drugs such as E-4031 and MK-499 are potent and specific blockers of I (Kr) in cardiac myocytes. Our initial studies indicated that these compounds did not block HERG at a concentration of 1 micromol/L. In the present study, we used standard two-microelectrode voltage-clamp techniques to further characterize the effects of these drugs on HERG channels expressed in oocytes. Consistent with initial findings, 1 micromol/L MK-499 and E-4031 had not effect on HERG when oocytes were voltage clamped at a negative potential and not pulsed during equilibration with the drug. However, MK-499 did block HERG current if oocytes were repetitively pulsed, or clamped at a voltage positive to the threshold potential for channel activation. This finding is in contrast to previous studies that showed significant block of I(Kr) in isolated myocytes by similar drugs, even in the absence of pulsing. This apparent discr...Continue Reading

Citations

Dec 16, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·Claudia KieseckerJohann Kiehn
Dec 20, 2005·The Journal of Membrane Biology·L A PardoW Stühmer
Aug 19, 2009·Pflügers Archiv : European journal of physiology·Wiebke HirdesChristiane K Bauer
Nov 15, 2011·Pflügers Archiv : European journal of physiology·Günter GlassmeierJürgen R Schwarz
Jul 27, 2007·Cell Biochemistry and Biophysics·Leonardo HernandezFederico Sesti
Jun 1, 2010·Archives of Pharmacal Research·Ki-Suk KimEun-Joo Kim
Apr 28, 2004·Cell Calcium·Ursula RavensOttó Hála
Jan 20, 2004·European Journal of Pharmacology·Martin TraebertWilli Suter
Aug 4, 2004·Progress in Biophysics and Molecular Biology·William BainsCat White
Jun 7, 2005·Journal of Pharmacological and Toxicological Methods·Jian-An YaoPhilip Atterson
Feb 13, 2001·European Journal of Pharmacology·K FinlaysonJ S Kelly
Dec 20, 2003·Progress in Cardiovascular Diseases·Ian W GlaaserColleen E Clancy
Oct 24, 1998·Progress in Biophysics and Molecular Biology·E Carmeliet, K Mubagwa
May 8, 2001·Trends in Pharmacological Sciences·J I VandenbergT J Campbell
Apr 30, 1999·Molecular and Cellular Endocrinology·C K BauerJ R Schwarz
Jul 18, 2000·Journal of the American College of Cardiology·C E Chiang, D M Roden
Jun 1, 1996·Current Opinion in Genetics & Development·M T Keating, M C Sanguinetti
Apr 3, 2001·Trends in Cardiovascular Medicine·J Kiehn
Dec 15, 2011·Expert Reviews in Molecular Medicine·Jodene Eldstrom, David Fedida
Sep 10, 2011·Journal of Chemical Information and Modeling·Lei Du-CunyShuxing Zhang
Mar 4, 1998·British Journal of Pharmacology·A E BuschF Lang
Oct 8, 1999·British Journal of Pharmacology·A G TeschemacherH J Witchel
Sep 5, 2002·British Journal of Pharmacology·Edgar ZitronJohann Kiehn
Oct 7, 2000·Clinical and Experimental Pharmacology & Physiology·H J Witchel, J C Hancox
Jun 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Tinatin I BrelidzeWilliam N Zagotta
Jun 17, 1998·The Journal of General Physiology·W ZhouT E DeCoursey
Feb 29, 2000·The Journal of General Physiology·J S MitchesonM C Sanguinetti
Aug 30, 2012·The Journal of General Physiology·Vivek GargMichael C Sanguinetti
Nov 1, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Natalia A TrayanovaFijoy Vadakkumpadan
May 19, 2010·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·A CorriasB Rodriguez
Apr 22, 2005·Acta Pharmacologica Sinica·Cuk-seong KimJin-bong Park
Jul 22, 1999·Annals of the New York Academy of Sciences·B GanetzkyS A Titus
Jul 22, 1999·Annals of the New York Academy of Sciences·M C Sanguinetti
Feb 14, 2006·Molecular Pharmacology·Kaichiro KamiyaMichael C Sanguinetti
Jan 24, 2003·Annual Review of Pharmacology and Toxicology·Colleen E ClancyRobert S Kass
Aug 17, 2012·American Journal of Physiology. Cell Physiology·Robert WondergemDavid L Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.